CHAM, Switzerland, Oct. 24 -- CNS Drugs, a peer-reviewed journal that says it provides researchers and healthcare professionals with information on the aspects of drug therapies used for the management of neurological and psychiatric disorders, published research articles on the following topics in its November 2024 edition (Vol. 38, Issue 11):

* An Open-Label Extension Study Assessing the Long-Term Safety and Efficacy of Viloxazine Extended-Release Capsules in Adults with Attention . . .

Click here for more information about our products